Cargando…

Prednisolone enhancement of primary endocrine anticancer treatment: a possible anti-angiogenic effect.

Detalles Bibliográficos
Autor principal:	Beranek, J. T.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1989
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247353/ https://www.ncbi.nlm.nih.gov/pubmed/2478179

Ejemplares similares

Prednisolone improves the response to primary endocrine treatment for advanced breast cancer.
por: Rubens, R. D., et al.
Publicado: (1988)

Overcoming Intrinsic Doxorubicin Resistance in Melanoma by Anti-Angiogenic and Anti-Metastatic Effects of Liposomal Prednisolone Phosphate on Tumor Microenvironment
por: Licarete, Emilia, et al.
Publicado: (2020)

Designing fisetin nanocrystals for enhanced in cellulo anti-angiogenic and anticancer efficacy()
por: Ma, Panpan, et al.
Publicado: (2022)

Prednisolone induced pneumatosis coli and pneumoperitoneum
por: Goh, Serene S N, et al.
Publicado: (2022)

The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1
por: Daghero, Hellen, et al.
Publicado: (2020)

Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
por: Tacey, Alexander, et al.
Publicado: (2019)

Successful Treatment of Refractory Diamond-Blackfan Anemia Using Metoclopramide and Prednisolone
por: Malbora, Barış, et al.
Publicado: (2012)

Bisphosphonate-related osteonecrosis of jaw (BRONJ): an anti-angiogenic side-effect?
por: Petcu, Eugen B, et al.
Publicado: (2012)

Apparent steroid resistance associated with prednisolone suspension
por: Sathe, K. P.
Publicado: (2014)

Effectiveness of a Low Dose Prednisolone Regimen for Treatment of Relapses in Children with Steroid Sensitive Nephrotic Syndrome
por: Kalra, Suprita, et al.
Publicado: (2023)

Successful treatment of recurrent follicular B-cell lymphoma with clarithromycin, prednisolone, and cyclophosphamide
por: Ohe, Masashi, et al.
Publicado: (2013)

A Randomized Trial of Liposomal Prednisolone (LIPMAT) to Enhance Radiocephalic Fistula Maturation: A Pilot Study
por: Voorzaat, Bram M., et al.
Publicado: (2020)

Megadose Methyl-Prednisolone (MDMP) for Autoimmune Hemolytic Anemia
por: Özsoylu, Şinasi
Publicado: (2013)

Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
por: Rui, Xin, et al.
Publicado: (2017)

Limitations of Anti-Angiogenic Treatment of Tumors
por: Ribatti, Domenico, et al.
Publicado: (2019)

Mechanisms of resistance to anti-angiogenic treatments
por: Pezzella, Francesco
Publicado: (2019)

Vessel co-option in primary human tumors and metastases: an obstacle to effective anti-angiogenic treatment?
por: Donnem, Tom, et al.
Publicado: (2013)

Hydrocortisone associated hypomania in a child responding to shifting back to prednisolone
por: Grover, Sandeep, et al.
Publicado: (2014)

Anti-Angiogenic Effect of Triptolide in Rheumatoid Arthritis by Targeting Angiogenic Cascade
por: Kong, Xiangying, et al.
Publicado: (2013)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
por: Kuljaca, Selena, et al.
Publicado: (2007)

Mithramycin Exerts an Anti-Myeloma Effect and Displays Anti-Angiogenic Effects through Up-Regulation of Anti-Angiogenic Factors
por: Otjacques, Eléonore, et al.
Publicado: (2013)

Prednisone and Prednisolone in the Treatment of Rheumatoid Arthritis
por: Montgomery, D. A. D.
Publicado: (1957)

Is Prednisolone Useful in Treatment of Hyperemesis Gravidarum?
por: Asmat, Aroosha, et al.
Publicado: (2020)

Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs
por: Pasquier, E, et al.
Publicado: (2013)

The antioxidant, anti-angiogenic, and anticancer impact of chitosan-coated herniarin-graphene oxide nanoparticles (CHG-NPs)
por: Jasim, Louay Mohammed Musa, et al.
Publicado: (2023)

Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
por: Wohlfeil, Sebastian A., et al.
Publicado: (2022)

Intraoperative refractory hypotension in a patient with chronic use of low-dose prednisolone
por: Ito, Shingo, et al.
Publicado: (2020)

Angiogenic signaling pathways and anti-angiogenic therapy for cancer
por: Liu, Zhen-Ling, et al.
Publicado: (2023)

Multiple endocrine neoplasia and primary hyperparathyroidism – practical approach
por: Koza, Jarosław
Publicado: (2015)

The Effect of Intratympanic Dexamethasone with Oral Prednisolone as a Primary Treatment in Idiopathic Sudden Sensorineural Hearing Loss
por: Khorsandi Ashtiani, Mohammad Taghi, et al.
Publicado: (2012)

Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma'
por: Ji, Y, et al.
Publicado: (2013)

Low-dose prednisolone in patients with paroxysmal nocturnal hemoglobinuria and inadequate response to eculizumab
por: Moon, Ji Young, et al.
Publicado: (2017)

Oral prednisolone for 4 days does not increase exercise tolerance in men with COPD
por: Karlsson, SL, et al.
Publicado: (2017)

Dexamethasone to prednisolone rotation relieved hiccups in colorectal cancer patient continuing teleworking during anticancer therapy
por: Nagata, Takuya, et al.
Publicado: (2023)

Enhanced anti‐angiogenic activity of novel melatonin‐like agents
por: Hwang, Su Jung, et al.
Publicado: (2021)

Anti-angiogenic assay assists fetal extraction decision in a case of pre-eclampsia suspicion?
por: Boulanger, Henri, et al.
Publicado: (2010)

6-Methyl Prednisolone in the Treatment of Rheumatoid Arthritis
por: Montgomery, D. A. D.
Publicado: (1958)

Scleromyxedema without Paraproteinemia: Treatment with Thalidomide and Prednisolone
por: Saniee, Sara, et al.
Publicado: (2016)

Combined Anti-Angiogenic and Anti-Inflammatory Nanoformulation for Effective Treatment of Ocular Vascular Diseases
por: Sun, Jianguo, et al.
Publicado: (2023)

Comparison of effects of anti-angiogenic agents in the zebrafish efficacy–toxicity model for translational anti-angiogenic drug discovery
por: Chimote, Geetanjali, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ohdeun8pg4ll5mnb706sp0qss2